Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 8,576 | 10,168 | 11,988 | 6,880 | 4,839 |
| Operating Income | -8,576 | -10,168 | -11,988 | -6,880 | -4,839 |
| Interest Expense | 6 | 75 | 0 | 0 | 0 |
| Other Income | -51 | -154 | -1,473 | 0 | 302 |
| Pre-tax Income | -8,632 | -10,397 | -13,461 | -6,880 | -4,537 |
| Net Income Continuous | -8,632 | -10,397 | -13,461 | -6,880 | -4,537 |
| Net Income | $-8,632 | $-10,397 | $-13,461 | $-6,880 | $-4,537 |
| EPS Basic Total Ops | -0.20 | -0.27 | -0.40 | -0.21 | -0.19 |
| EPS Basic Continuous Ops | -0.20 | -0.27 | -0.40 | -0.22 | -0.18 |
| EPS Diluted Total Ops | -0.20 | -0.27 | -0.40 | -0.21 | -0.19 |
| EPS Diluted Continuous Ops | -0.20 | -0.27 | -0.40 | -0.22 | -0.18 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.27 | -0.41 | -0.21 | -0.19 |
| EBITDA(a) | $-8,446 | $-9,974 | $-10,825 | $-6,755 | $-4,726 |